GlycoMimetics Director Acquires $8,000,000 in Stock (GLYC)
GlycoMimetics (NASDAQ:GLYC) Director M James Barrett acquired 1,000,000 shares of the stock on the open market in a transaction that occurred on Wednesday, January 15th. The shares were purchased at an average price of $8.00 per share, for a total transaction of $8,000,000.00. The acquisition was disclosed in a document filed with the SEC, which is available at this link.
Shares of GlycoMimetics (NASDAQ:GLYC) traded up 7.24% during mid-day trading on Wednesday, hitting $9.63. The stock had a trading volume of 238,584 shares. GlycoMimetics has a 52-week low of $8.40 and a 52-week high of $9.04. The stock’s 50-day moving average is $8.8 and its 200-day moving average is $8.8. The company’s market cap is $12.0 million.
GlycoMimetics, Inc (NASDAQ:GLYC) is a clinical-stage biotechnology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.